48 results on '"Sosabowski, Jane K."'
Search Results
2. Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy
3. Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo
4. High-throughput high-volume nuclear imaging for preclinical in vivo compound screening§
5. Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood–brain barrier in vitro and in vivo
6. Kinetics of functionalised carbon nanotube distribution in mouse brain after systemic injection: Spatial to ultra-structural analyses
7. Anesthesia and Monitoring of Animals During MRI Studies
8. Evaluation and comparison of a new DOTA and DTPA-bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models
9. Pre-clinical quantitative imaging and mouse-specific dosimetry for 111In-labelled radiotracers
10. The relationship between the diameter of chemically-functionalized multi-walled carbon nanotubes and their organ biodistribution profiles in vivo
11. Radiopeptide internalisation and externalisation assays: Cell viability and radioligand integrity
12. Radiolabelled peptides for oncological diagnosis
13. Comparative biodistribution of 12 111In-labelled gastrin/CCK2 receptor-targeting peptides
14. Comparison of the binding and internalization properties of 12 DOTA-coupled and 111In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607
15. Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607
16. Neutron Activated 153Sm Sealed in Carbon Nanocapsules for in Vivo Imaging and Tumor Radiotherapy
17. Copper bis(diphosphine) complexes: radiopharmaceuticals for the detection of multi-drug resistance in tumours by PET
18. 18F-Trifluoromethanesulfinate Enables Direct C–H 18F-Trifluoromethylation of Native Aromatic Residues in Peptides
19. Organ Biodistribution of Radiolabelled γδ T Cells Following Liposomal Alendronate Administration in Different Mouse Tumour Models
20. Neutron Activated 153Sm Sealed in Carbon Nanocapsules for in Vivo Imaging and Tumor Radiotherapy
21. Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo
22. Formulation development and manufacturing of a gastrin/CCK-2 receptor targeting peptide as an intermediate drug product for a clinical imaging study
23. AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting
24. Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting: Erratum
25. Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting
26. Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting
27. The Shortening of MWNT-SPION Hybrids by Steam Treatment Improves Their Magnetic Resonance Imaging Properties In Vitro and In Vivo
28. Triple-Modal Imaging of Magnetically-Targeted Nanocapsules in Solid Tumours In Vivo
29. Neutron Activated 153Sm Sealed in Carbon Nanocapsules for in VivoImaging and Tumor Radiotherapy
30. The Shortening of MWNT-SPION Hybrids by Steam Treatment Improves Their Magnetic Resonance Imaging Properties In Vitro and In Vivo
31. Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptides
32. Comparison of the binding and internalization properties of 12 DOTA-coupled and ¹¹¹In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607
33. Adoptive Immunotherapy of Epithelial Ovarian Cancer with Vγ9Vδ2 T Cells, Potentiated by Liposomal Alendronic Acid
34. Contrast Agents: Magnetically Decorated Multiwalled Carbon Nanotubes as Dual MRI and SPECT Contrast Agents (Adv. Funct. Mater. 13/2014)
35. Magnetically Decorated Multiwalled Carbon Nanotubes as Dual MRI and SPECT Contrast Agents
36. Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity?
37. Quantitative Accuracy of Low-Count SPECT Imaging in Phantom and In Vivo Mouse Studies
38. Targeting of CCK-2 Receptor–Expressing Tumors Using a Radiolabeled Divalent Gastrin Peptide
39. Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes
40. Magnetically Decorated Multiwalled Carbon Nanotubes as Dual MRI and SPECT Contrast Agents.
41. ID 172. Engineering Hepatitis B Virus Core Particles for In vivo Nuclear Imaging to Localise HER-2 Expressing Tumours.
42. Selection of Radiolabeled Gastrin Analogs for Peptide Receptor-Targeted Radionuclide Therapy.
43. 99mTc-HYNIC [Tyr³]-Octreotide for Imaging Somatostatin-Receptor--Positive Tumors: Preclinical Evaluation and Comparison with 111In-Octreotide.
44. Pre-clinical quantitative imaging and mouse-specific dosimetry for 111In-labelled radiotracers
45. Neutron Activated 153 Sm Sealed in Carbon Nanocapsules for in Vivo Imaging and Tumor Radiotherapy.
46. 18 F-Trifluoromethanesulfinate Enables Direct C-H 18 F-Trifluoromethylation of Native Aromatic Residues in Peptides.
47. Erratum: Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting: Erratum.
48. Radiopeptide internalisation and externalization assays: cell viability and radioligand integrity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.